CEBPA MUTATION DETECTION / EDTA BLOOD

image not found

NABL Cap Accredited 

The CEBPA Mutation Detection / EDTA Blood test identifies mutations in the CEBPA gene, which are clinically significant in evaluating certain types of acute myeloid leukemia (AML). Metropolis Healthcare uses advanced molecular techniques to deliver accurate, reliable results. This test helps clinicians assess prognosis and guide treatment decisions. It is performed on an EDTA blood sample to ensure optimal DNA quality for analysis.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,300.00

Sample Type: EDTA BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You can make the payment to the technician at the time of collection
  4. Your sample will then be transported to the nearest collection center and will be centrifuged before sending to the lab for processing.
  5. Soft copy reports will be sent to your email address within 24 to 48 hours or as per defined TAT for Tests.

Frequently Asked Questions (FAQ's):

What does the CEBPA Mutation Detection test include?
This test analyzes the CEBPA gene for single or double mutations associated with AML, providing detailed molecular insights for disease evaluation.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses highly sensitive molecular assays to detect CEBPA mutations from an EDTA blood sample, ensuring precise and clinically meaningful results.

Who should undergo this test?
Patients being evaluated for acute myeloid leukemia or those with confirmed AML who need prognostic stratification may be advised to take this test.

What type of sample is required for the test?
An EDTA anticoagulated blood sample is required to preserve DNA integrity for reliable mutation analysis.

Why is CEBPA mutation status important?
CEBPA mutations carry significant prognostic value in AML and help clinicians tailor treatment strategies based on individual risk profiles.

How reliable are the results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality controls, validated protocols, and advanced molecular diagnostics to ensure high accuracy and reproducibility.

Do I need to prepare in any special way before giving the blood sample?
No fasting or special preparation is typically needed; however, patients should follow any additional instructions provided by their physician.

How long does it take to receive the test results?
Turnaround time may vary, but Metropolis Healthcare generally provides timely reports to support prompt clinical decision-making.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab